Characterization	O
of	O
the	O
nuclear	O
and	O
cytoplasmic	O
components	O
of	O
the	O
lymphoid-specific	B-protein
nuclear	I-protein
factor	I-protein
of	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
(	O
NF-AT	B-protein
)	O
complex	O
.	O

The	O
lymphoid-specific	B-protein
transcription	I-protein
complex	I-protein
,	O
NF-AT	B-protein
,	O
is	O
involved	O
in	O
early	O
gene	O
activation	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
is	O
assembled	O
from	O
a	O
pre-existing	O
,	O
T	B-protein
cell	I-protein
restricted	I-protein
cytoplasmic	I-protein
factor	I-protein
and	O
an	O
inducible	O
ubiquitous	B-protein
nuclear	B-protein
component	I-protein
within	O
30	O
min	O
after	O
activation	O
through	O
the	O
antigen	B-protein
receptor	I-protein
.	O

Recent	O
studies	O
have	O
implicated	O
the	O
family	O
of	O
AP1	B-protein
factors	I-protein
as	O
components	O
of	O
the	O
murine	B-protein
NF-AT	I-protein
complex	I-protein
.	O

Evidence	O
is	O
provided	O
here	O
that	O
the	O
nuclear	O
component	O
of	O
human	B-protein
NF-AT	I-protein
contains	O
the	O
phorbol	B-protein
ester-inducible	I-protein
transcription	I-protein
factor	I-protein
AP1	I-protein
(	O
Jun/Fos	B-protein
)	O
.	O

We	O
further	O
characterize	O
which	O
AP1	B-protein
family	I-protein
members	I-protein
can	O
assume	O
this	O
role	O
.	O

Antisera	O
to	O
Fos	B-protein
inhibits	O
NF-AT	B-protein
DNA	O
binding	O
as	O
does	O
an	O
oligonucleotide	O
containing	O
a	O
binding	B-DNA
site	I-DNA
for	I-DNA
AP1	I-DNA
.	O

Constitutive	O
expression	O
in	O
vivo	O
of	O
Fos	B-protein
,	O
and	O
to	O
a	O
lesser	O
extent	O
Fra-1	B-protein
,	O
eliminates	O
the	O
requirement	O
for	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
stimulation	O
,	O
leaving	O
NF-AT	B-protein
-directed	O
transcription	O
responsive	O
to	O
calcium	O
ionophore	O
alone	O
.	O

Overexpression	O
of	O
cJun	B-protein
or	O
JunD	B-protein
,	O
but	O
not	O
JunB	B-protein
,	O
also	O
eliminates	O
the	O
requirement	O
for	O
PMA	O
,	O
indicating	O
that	O
many	O
but	O
not	O
all	O
Jun-	B-protein
and	I-protein
Fos-related	I-protein
proteins	I-protein
functionally	O
activate	O
NF-AT	B-protein
-dependent	O
transcription	O
in	O
the	O
presence	O
of	O
the	O
cytoplasmic	O
component	O
.	O

NF-AT	B-protein
DNA	O
binding	O
can	O
be	O
reconstituted	O
in	O
vitro	O
using	O
semi-purified	B-protein
AP1	I-protein
proteins	I-protein
mixed	O
with	O
cytosol	O
from	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Fos	O
proteins	O
are	O
not	O
needed	O
for	O
this	O
reconstitution	O
,	O
and	O
although	O
JunB	B-protein
is	O
not	O
functional	O
,	O
it	O
can	O
participate	O
in	O
the	O
NF-AT	B-protein
DNA	I-protein
binding	I-protein
complex	I-protein
.	O

Finally	O
,	O
we	O
have	O
partially	O
purified	O
the	O
cytoplasmic	O
component	O
of	O
NF-AT	O
and	O
show	O
by	O
elution	O
and	O
renaturation	O
from	O
SDS-polyacrylamide	O
gel	O
electrophoresis	O
gels	O
that	O
it	O
has	O
a	O
molecular	O
mass	O
between	O
94	O
and	O
116	O
kDa	O
and	O
may	O
have	O
multiple	O
differentially	O
modified	O
forms	O
.	O

THe	NULL
JourNat	NULL
or	NULL
BroLogicat	NULL
CHEMISTRY	NULL
_	NULL
.	NULL

©1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

4	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

2917-2923	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
Nuclear	NULL
and	NULL
Cytoplasmic	NULL
Components	NULL
of	NULL
the	NULL
Lymphoid-specific	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
Cells	NULL
(	NULL
NF-AT	NULL
)	NULL
Complex	NULL
*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
3	NULL
,	NULL
1992	NULL
)	NULL
Jeffrey	NULL
P.	NULL
Northrop	NULL
,	NULL
Katharine	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
Gerald	NULL
R.	NULL
Crabtreet	NULL
From	NULL
the	NULL
Beckman	NULL
Center	NULL
for	NULL
Molecular	NULL
and	NULL
Genetic	NULL
Medicine	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
The	NULL
lymphoid-specific	NULL
transcription	NULL
complex	NULL
,	NULL
NF-AT	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
early	NULL
gene	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
assembled	NULL
from	NULL
a	NULL
pre-existing	NULL
,	NULL
T	NULL
cell	NULL
restricted	NULL
cytoplasmic	NULL
factor	NULL
and	NULL
an	NULL
inducible	NULL
ubiquitous	NULL
nuclear	NULL
component	NULL
within	NULL
30	NULL
min	NULL
after	NULL
activation	NULL
through	NULL
the	NULL
antigen	NULL
receptor	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
implicated	NULL
the	NULL
family	NULL
of	NULL
API	NULL
factors	NULL
as	NULL
components	NULL
of	NULL
the	NULL
murine	NULL
NF-AT	NULL
complex	NULL
.	NULL

Evidence	NULL
is	NULL
provided	NULL
here	NULL
that	NULL
the	NULL
nuclear	NULL
component	NULL
of	NULL
human	NULL
NF-AT	NULL
contains	NULL
the	NULL
phorbol	NULL
es-ter-inducible	NULL
transcription	NULL
factor	NULL
APL	NULL
(	NULL
Jun/Fos	NULL
)	NULL
.	NULL

We	NULL
further	NULL
characterize	NULL
which	NULL
API	NULL
family	NULL
members	NULL
can	NULL
assume	NULL
this	NULL
role	NULL
.	NULL

Antisera	NULL
to	NULL
Fos	NULL
inhibits	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
as	NULL
does	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
AP1	NULL
.	NULL

Constitutive	NULL
expression	NULL
in	NULL
vivo	NULL
of	NULL
Fos	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
Fra-1	NULL
,	NULL
eliminates	NULL
the	NULL
requirement	NULL
for	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
stimulation	NULL
,	NULL
leaving	NULL
NF-AT-directed	NULL
transcription	NULL
responsive	NULL
to	NULL
calcium	NULL
ionophore	NULL
alone	NULL
.	NULL

Overexpression	NULL
of	NULL
cJun	NULL
or	NULL
JunD	NULL
,	NULL
but	NULL
not	NULL
JunB	NULL
,	NULL
also	NULL
eliminates	NULL
the	NULL
requirement	NULL
for	NULL
PMA	NULL
,	NULL
indicating	NULL
that	NULL
many	NULL
but	NULL
not	NULL
all	NULL
Jun-	NULL
and	NULL
Fos-related	NULL
proteins	NULL
functionally	NULL
activate	NULL
NF-AT-dependent	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
.	NULL

NF-AT	NULL
DNA	NULL
binding	NULL
can	NULL
be	NULL
reconstituted	NULL
in	NULL
vitro	NULL
using	NULL
semi-purified	NULL
AP	NULL
1	NULL
proteins	NULL
mixed	NULL
with	NULL
cytosol	NULL
from	NULL
T	NULL
lymphocytes	NULL
.	NULL

Fos	NULL
proteins	NULL
are	NULL
not	NULL
needed	NULL
for	NULL
this	NULL
reconstitution	NULL
,	NULL
and	NULL
although	NULL
JunB	NULL
is	NULL
not	NULL
functional	NULL
,	NULL
it	NULL
can	NULL
participate	NULL
in	NULL
the	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
complex	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
partially	NULL
purified	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NF-AT	NULL
and	NULL
show	NULL
by	NULL
elution	NULL
and	NULL
renaturation	NULL
from	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
gels	NULL
that	NULL
it	NULL
has	NULL
a	NULL
molecular	NULL
mass	NULL
between	NULL
94	NULL
and	NULL
116	NULL
kDa	NULL
and	NULL
may	NULL
have	NULL
multiple	NULL
dif-ferentially	NULL
modified	NULL
forms	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
is	NULL
largely	NULL
derived	NULL
from	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
of	NULL
T	NULL
lymphocytes	NULL
to	NULL
rapidly	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
that	NULL
in	NULL
turn	NULL
control	NULL
cell	NULL
fate	NULL
decisions	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
macrophages	NULL
,	NULL
granulocytes	NULL
,	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
necessary	NULL
for	NULL
an	NULL
effective	NULL
immune	NULL
response	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
evidence	NULL
has	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL33942	NULL
and	NULL
CA39612	NULL
(	NULL
to	NULL
G.	NULL
R.	NULL
C.	NULL
)	NULL
and	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
to	NULL
J.	NULL
P.	NULL
N.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

£	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

implicated	NULL
NF-AT	NULL
``	NULL
as	NULL
a	NULL
specific	NULL
nuclear	NULL
target	NULL
for	NULL
the	NULL
antigen	NULL
receptor	NULL
conveying	NULL
its	NULL
specificity	NULL
to	NULL
the	NULL
early	NULL
activation	NULL
cytokines	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
molecular	NULL
makeup	NULL
of	NULL
NF-AT	NULL
is	NULL
at	NULL
present	NULL
unknown	NULL
,	NULL
recent	NULL
studies	NULL
(	NULL
7	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
NF-AT	NULL
can	NULL
be	NULL
reconstituted	NULL
from	NULL
a	NULL
ubiquitous	NULL
nuclear	NULL
component	NULL
that	NULL
requires	NULL
protein	NULL
synthesis	NULL
for	NULL
induction	NULL
and	NULL
a	NULL
T	NULL
cell-specific	NULL
constitutive	NULL
cytoplasmic	NULL
component	NULL
(	NULL
NF-AT	NULL
,	NULL
)	NULL
.	NULL

This	NULL
cytoplasmic	NULL
component	NULL
associates	NULL
with	NULL
the	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
calcium	NULL
signaling	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
immunosupressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
.	NULL

Like	NULL
the	NULL
nuclear	NULL
component	NULL
of	NULL
NF-AT	NULL
,	NULL
API	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
many	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

AP1	NULL
can	NULL
contain	NULL
any	NULL
one	NULL
of	NULL
a	NULL
group	NULL
of	NULL
related	NULL
proto-oncogenes	NULL
,	NULL
the	NULL
Jun	NULL
family	NULL
(	NULL
8-12	NULL
)	NULL
,	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
specific	NULL
responsive	NULL
elements	NULL
as	NULL
homodimers	NULL
(	NULL
8-13	NULL
)	NULL
or	NULL
as	NULL
heterodimers	NULL
with	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
13-17	NULL
)	NULL
or	NULL
with	NULL
other	NULL
Fos-related	NULL
proteins	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
component	NULL
of	NULL
NF-AT	NULL
can	NULL
be	NULL
induced	NULL
with	NULL
PMA	NULL
,	NULL
is	NULL
not	NULL
sensitive	NULL
to	NULL
CsA	NULL
or	NULL
FK506	NULL
,	NULL
and	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
cells	NULL
of	NULL
non-T	NULL
cell	NULL
origin	NULL
such	NULL
as	NULL
HeLa	NULL
(	NULL
7	NULL
)	NULL
and	NULL
Cos	NULL
cells	NULL
.	NULL
``	NULL

Transcription	NULL
of	NULL
the	NULL
proto-oncogene	NULL
c-fos	NULL
occurs	NULL
within	NULL
30	NULL
min	NULL
following	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
and	NULL
is	NULL
insensitive	NULL
to	NULL
CsA	NULL
and	NULL
FK506	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
these	NULL
simi-larities	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
Fos	NULL
or	NULL
a	NULL
Fos-related	NULL
antigen	NULL
(	NULL
Fra	NULL
)	NULL
might	NULL
participate	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NF-AT	NULL
complex	NULL
.	NULL

Recent	NULL
studies	NULL
(	NULL
23	NULL
)	NULL
have	NULL
implicated	NULL
Fos	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
murine	NULL
NF-AT	NULL
complex	NULL
;	NULL
however	NULL
,	NULL
the	NULL
antisera	NULL
used	NULL
in	NULL
this	NULL
work	NULL
recognizes	NULL
the	NULL
Fos	NULL
M	NULL
peptide	NULL
which	NULL
is	NULL
essentially	NULL
conserved	NULL
in	NULL
every	NULL
Fos-related	NULL
protein	NULL
thus	NULL
far	NULL
identified	NULL
including	NULL
FosB	NULL
,	NULL
FosB2	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
portion	NULL
of	NULL
the	NULL
murine	NULL
NF-AT	NULL
complex	NULL
binds	NULL
to	NULL
an	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
IL-2	NULL
enhancer	NULL
containing	NULL
a	NULL
6	NULL
of	NULL
7	NULL
base	NULL
pair	NULL
match	NULL
with	NULL
a	NULL
consensus	NULL
AP1	NULL
binding	NULL
site	NULL
and	NULL
may	NULL
contain	NULL
one	NULL
of	NULL
the	NULL
known	NULL
Jun	NULL
proteins	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
expressing	NULL
the	NULL
SV40	NULL
T	NULL
antigen	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
human	NULL
NF-AT	NULL
.	NULL

We	NULL
find	NULL
that	NULL
any	NULL
of	NULL
three	NULL
Jun	NULL
family	NULL
members	NULL
can	NULL
complement	NULL
T	NULL
cell	NULL
cytosol	NULL
to	NULL
form	NULL
NF-AT	NULL
binding	NULL
activity	NULL
in	NULL
vitro	NULL
but	NULL
only	NULL
eJun	NULL
and	NULL
JunD	NULL
,	NULL
not	NULL
JunB	NULL
,	NULL
are	NULL
able	NULL
to	NULL
functionally	NULL
replace	NULL
PMA	NULL
induction	NULL
of	NULL
this	NULL
component	NULL
in	NULL
vivo	NULL
.	NULL

Both	NULL
Fos	NULL
and	NULL
Fra-1	NULL
can	NULL
functionally	NULL
replace	NULL
PMA	NULL
in-duction	NULL
,	NULL
and	NULL
although	NULL
Fos	NULL
protein	NULL
can	NULL
participate	NULL
in	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
it	NULL
is	NULL
not	NULL
necessary	NULL
;	NULL
Jun	NULL
alone	NULL
can	NULL
form	NULL
'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NF-AT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
HNF-1	NULL
@	NULL
,	NULL
hepatocyte	NULL
nuclear	NULL
factor-l1a	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
IL-2	NULL
,	NULL
interleukin-2	NULL
;	NULL
Oct-1	NULL
,	NULL
octamer	NULL
factor-1	NULL
;	NULL
Fra	NULL
,	NULL
Fos-related	NULL
antigen	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
Tag	NULL
,	NULL
T	NULL
antigen	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethylsulfonyl	NULL
flu-oride	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
.	NULL

*	NULL
J.	NULL
Northrop	NULL
and	NULL
G.	NULL
Crabtree	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

2917	NULL
2918	NULL
the	NULL
nuclear	NULL
component	NULL
.	NULL

We	NULL
have	NULL
partially	NULL
purified	NULL
the	NULL
cytoplasmic	NULL
component	NULL
and	NULL
find	NULL
that	NULL
it	NULL
has	NULL
a	NULL
molecular	NULL
mass	NULL
between	NULL
94	NULL
and	NULL
116	NULL
kDa	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Jurkat	NULL
Cells	NULL
Expressing	NULL
SV40	NULL
T	NULL
Antigen-The	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
humidified	NULL
atmosphere	NULL
.	NULL

A	NULL
construct	NULL
for	NULL
expression	NULL
of	NULL
SV40	NULL
T	NULL
antigen	NULL
,	NULL
RSV	NULL
Tag	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
a	NULL
2.6-kilbase	NULL
pair	NULL
HindIII/BamHI	NULL
fragment	NULL
of	NULL
SV40	NULL
in	NULL
place	NULL
of	NULL
ther	NULL
CAT	NULL
gene	NULL
in	NULL
RSVCAT	NULL
(	NULL
24	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
construct	NULL
,	NULL
RSVneo	NULL
,	NULL
was	NULL
made	NULL
by	NULL
inserting	NULL
the	NULL
neomycin	NULL
resistance	NULL
gene	NULL
(	NULL
HindIII/BamHI	NULL
fragment	NULL
)	NULL
from	NULL
pSV2neo	NULL
(	NULL
25	NULL
)	NULL
in	NULL
place	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
RSVCAT	NULL
.	NULL

The	NULL
RSV	NULL
neo	NULL
cassett	NULL
was	NULL
removed	NULL
with	NULL
Ndel/BamHI	NULL
and	NULL
blunted	NULL
into	NULL
the	NULL
unique	NULL
Apal	NULL
site	NULL
of	NULL
RSV	NULL
Tag	NULL
forming	NULL
RSV	NULL
Tagneo	NULL
.	NULL

Twenty	NULL
ug	NULL
of	NULL
this	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
BamHI	NULL
and	NULL
electroporated	NULL
(	NULL
240	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
)	NULL
into	NULL
the	NULL
NF-AT	NULL
lacZ-positive	NULL
cell	NULL
line	NULL
J.NFATZ.1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Selections	NULL
were	NULL
done	NULL
using	NULL
G418	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
until	NULL
resistant	NULL
clones	NULL
grew	NULL
out	NULL
.	NULL

Expression	NULL
of	NULL
T	NULL
antigen	NULL
in	NULL
individual	NULL
clones	NULL
was	NULL
assayed	NULL
by	NULL
ribonuclease	NULL
protection	NULL
and	NULL
by	NULL
immunofluorescence	NULL
.	NULL

Clone	NULL
15	NULL
,	NULL
TagC15	NULL
,	NULL
expresses	NULL
approximately	NULL
30	NULL
%	NULL
as	NULL
much	NULL
T	NULL
antigen	NULL
mRNA	NULL
as	NULL
do	NULL
Cos	NULL
cells	NULL
and	NULL
contains	NULL
positive	NULL
nuclear	NULL
staining	NULL
for	NULL
the	NULL
T	NULL
antigen	NULL
.	NULL

These	NULL
cells	NULL
consistently	NULL
express	NULL
higher	NULL
levels	NULL
of	NULL
transfected	NULL
genes	NULL
driven	NULL
from	NULL
SVA40	NULL
origin-containing	NULL
vectors	NULL
as	NULL
compared	NULL
with	NULL
non-T	NULL
antigen-containing	NULL
Jurkat	NULL
cells	NULL
``	NULL
and	NULL
have	NULL
been	NULL
used	NULL
extensively	NULL
for	NULL
expression	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
proteins	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Gel	NULL
Mobility	NULL
Shifts-A	NULL
nuclear	NULL
extract	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
h.	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
2	NULL
um	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
)	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Rat	NULL
liver	NULL
nuclear	NULL
extract	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
D.	NULL
Mendel	NULL
and	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1.7	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
with	NULL
or	NULL
without	NULL
antisera	NULL
(	NULL
0.5	NULL
ul	NULL
)	NULL
or	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
25	NULL
ng	NULL
,	NULL
200-fold	NULL
excess	NULL
)	NULL
.	NULL

End-labeled	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
then	NULL
added	NULL
to	NULL
each	NULL
mixture	NULL
and	NULL
incubations	NULL
carried	NULL
out	NULL
for	NULL
another	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
,	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
:	NULL
0.089	NULL
m	NULL
Tris	NULL
base	NULL
,	NULL
0.081	NULL
M	NULL
boric	NULL
acid	NULL
,	NULL
0.002	NULL
m	NULL
EDTA	NULL
,	NULL
pH	NULL
8.4	NULL
)	NULL
-containing	NULL
gels	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
,	NULL
NF-AT	NULL
(	NULL
5-GATCTAAGGAGGAAAAACTGTTTCATGGATC-3	NULL
'	NULL
)	NULL
,	NULL
AP1	NULL
(	NULL
5'-TCGAGTGACTCAGCGCGTCGA-3	NULL
'	NULL
)	NULL
,	NULL
Oct-	NULL
(	NULL
5-GATCTTT-GAAAATATGTGTAATATGTAAAACATTTTGGATC-3	NULL
'	NULL
)	NULL
,	NULL
__	NULL
and	NULL
HNF	NULL
(	NULL
828	NULL
probe	NULL
as	NULL
defined	NULL
,	NULL
Ref	NULL
.	NULL

29	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
immunoglobulin	NULL
«	NULL
-chain	NULL
enhancer	NULL
E-box	NULL
containing	NULL
oligonucleotide	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
Antisera	NULL
to	NULL
HNF-1a	NULL
has	NULL
been	NULL
described	NULL
(	NULL
27	NULL
)	NULL
as	NULL
has	NULL
the	NULL
antisera	NULL
to	NULL
Fos	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Antisera	NULL
specific	NULL
for	NULL
JunD	NULL
was	NULL
raised	NULL
in	NULL
Balb/c	NULL
mice	NULL
using	NULL
a	NULL
protein	NULL
containing	NULL
a	NULL
region	NULL
of	NULL
human	NULL
JunD	NULL
(	NULL
gift	NULL
of	NULL
N.	NULL
Nomura	NULL
)	NULL
spanning	NULL
from	NULL
amino	NULL
acid	NULL
44	NULL
to	NULL
193	NULL
fused	NULL
to	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
gluta-thione	NULL
S-transferase	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
A	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

NF-AT	NULL
contains	NULL
an	NULL
API	NULL
binding	NULL
activity	NULL
and	NULL
is	NULL
immunologically	NULL
cross-reactive	NULL
with	NULL
Fos	NULL
.	NULL

A	NULL
,	NULL
inhibition	NULL
of	NULL
NF-AT	NULL
and	NULL
AP1	NULL
DNA	NULL
binding	NULL
activities	NULL
using	NULL
anti-Fos	NULL
antibodies	NULL
.	NULL

Jurkat	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
1-9	NULL
)	NULL
or	NULL
rat	NULL
liver	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
10-12	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
no	NULL
additions	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
or	NULL
with	NULL
0.5	NULL
ul	NULL
of	NULL
anti-M	NULL
peptide	NULL
antisera	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
or	NULL
0.5	NULL
ul	NULL
of	NULL
antisera	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
before	NULL
adding	NULL
the	NULL
indicated	NULL
end	NULL
labeled	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

Spe-	NULL
B	NULL
cific	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

B	NULL
,	NULL
cross-competition	NULL
between	NULL
NF-AT	NULL
and	NULL
AP1	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
done	NULL
using	NULL
Jurkat	NULL
nuclear	NULL
extract	NULL
as	NULL
in	NULL
A	NULL
except	NULL
that	NULL
preincubations	NULL
were	NULL
done	NULL
with	NULL
either	NULL
no	NULL
competitor	NULL
or	NULL
with	NULL
the	NULL
specified	NULL
competitor	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
using	NULL
the	NULL
NF-AT	NULL
probe	NULL
;	NULL
lanes	NULL
5-8	NULL
,	NULL
using	NULL
the	NULL
AP1	NULL
probe	NULL
.	NULL

Antisera	NULL
Competitor	NULL
NF-AT	NULL
-	NULL
»	NULL
»	NULL
Components	NULL
of	NULL
NF-AT	NULL
using	NULL
glutathione-agarose	NULL
and	NULL
mixed	NULL
with	NULL
trehalose	NULL
dimycolate	NULL
emulsion	NULL
(	NULL
RIBI	NULL
Immunochem	NULL
Research	NULL
,	NULL
Inc.	NULL
)	NULL
prior	NULL
to	NULL
intraperitoneal	NULL
injection	NULL
.	NULL

Transfections-Luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
as	NULL
follows	NULL
.	NULL

NF-ATLuc	NULL
was	NULL
provided	NULL
by	NULL
Peter	NULL
Kao	NULL
and	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NF-AT	NULL
binding	NULL
site	NULL
(	NULL
-286	NULL
to	NULL
-257	NULL
of	NULL
human	NULL
IL-2	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
-72	NULL
to	NULL
+47	NULL
)	NULL
driving	NULL
luciferase	NULL
(	NULL
31	NULL
)	NULL
.	NULL

NFxBLuc	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
human	NULL
immunoglobulin	NULL
«	NULL
-chain	NULL
enhancer	NULL
B	NULL
site	NULL
(	NULL
22	NULL
)	NULL
in	NULL
place	NULL
of	NULL
the	NULL
three	NULL
NF-AT	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
IL-2Luc	NULL
contains	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer/promoter	NULL
sequence	NULL
-326	NULL
to	NULL
+47	NULL
.	NULL

The	NULL
expression	NULL
constructs	NULL
SVFos	NULL
,	NULL
RSVeJun	NULL
,	NULL
RSVJunB	NULL
,	NULL
and	NULL
RSVJunD	NULL
encoding	NULL
murine	NULL
cFos	NULL
,	NULL
cJun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
a	NULL
gift	NULL
of	NULL
M.	NULL
Yaniv	NULL
.	NULL

An	NULL
expression	NULL
vector	NULL
for	NULL
murine	NULL
JunD	NULL
tagged	NULL
with	NULL
6	NULL
histidine	NULL
residues	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
was	NULL
constructed	NULL
by	NULL
placing	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
murine	NULL
jun	NULL
)	NULL
into	NULL
the	NULL
bacterial	NULL
expression	NULL
vector	NULL
QE-9	NULL
(	NULL
Quiagen	NULL
)	NULL
.	NULL

An	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
sequences	NULL
encoding	NULL
the	NULL
histidine	NULL
tail	NULL
as	NULL
well	NULL
as	NULL
the	NULL
entire	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
junD	NULL
was	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBJ5	NULL
,	NULL
placing	NULL
it	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
SRa	NULL
«	NULL
promoter	NULL
.	NULL

These	NULL
manipulations	NULL
added	NULL
the	NULL
sequence	NULL
Met-Arg-Gly-Ser-His-His-His-His-His-His-Gly-Ser-Pro	NULL
to	NULL
the	NULL
amino	NULL
end	NULL
of	NULL
JunD	NULL
.	NULL

Transfection	NULL
of	NULL
this	NULL
construct	NULL
into	NULL
Jurkat	NULL
cells	NULL
indicates	NULL
that	NULL
it	NULL
remains	NULL
functional	NULL
.	NULL
``	NULL

An	NULL
expression	NULL
vector	NULL
for	NULL
murine	NULL
cFos	NULL
tagged	NULL
with	NULL
6	NULL
histidine	NULL
residues	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
was	NULL
constructed	NULL
by	NULL
cloning	NULL
genomic	NULL
sequences	NULL
between	NULL
the	NULL
unique	NULL
Bgll	NULL
site	NULL
and	NULL
the	NULL
Nae	NULL
!	NULL

site	NULL
immediately	NULL
downstream	NULL
from	NULL
the	NULL
stop	NULL
codon	NULL
into	NULL
the	NULL
vector	NULL
QE-9	NULL
.	NULL

A	NULL
fragment	NULL
containing	NULL
the	NULL
histidine	NULL
tag	NULL
and	NULL
these	NULL
genomic	NULL
sequences	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBJ5	NULL
as	NULL
above	NULL
.	NULL

This	NULL
procedure	NULL
removed	NULL
the	NULL
first	NULL
21	NULL
amino	NULL
acids	NULL
of	NULL
Fos	NULL
and	NULL
replaced	NULL
them	NULL
with	NULL
the	NULL
sequence	NULL
Met-Arg-Gly-Ser-His-His-	NULL
His-	NULL
His-His-His-Gly-Ser-Val-Asp	NULL
.	NULL

This	NULL
construct	NULL
also	NULL
remains	NULL
functional	NULL
as	NULL
assayed	NULL
by	NULL
transfection	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL
``	NULL

Expression	NULL
vectors	NULL
for	NULL
rat	NULL
cFos	NULL
and	NULL
rat	NULL
Fra-1	NULL
were	NULL
constructed	NULL
by	NULL
cloning	NULL
EcoRI	NULL
fragments	NULL
containing	NULL
the	NULL
entire	NULL
coding	NULL
sequence	NULL
for	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBJ5	NULL
.	NULL

Jurkat	NULL
cells	NULL
expressing	NULL
the	NULL
SV40	NULL
T	NULL
antigen	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
240	NULL
V	NULL
,	NULL
960	NULL
LF	NULL
)	NULL
with	NULL
luciferase-based	NULL
reporter	NULL
constructs	NULL
for	NULL
NF-AT	NULL
,	NULL
NFxB	NULL
,	NULL
and	NULL
the	NULL
IL-2	NULL
enhancer/promoter	NULL
and	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
cFos	NULL
,	NULL
Fra-1	NULL
,	NULL
cJun	NULL
,	NULL
JunB	NULL
JunD	NULL
,	NULL
or	NULL
pBJ5	NULL
control	NULL
plasmid	NULL
.	NULL

Each	NULL
transfection	NULL
contained	NULL
2	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
and	NULL
4	NULL
ug	NULL
of	NULL
expression	NULL
construct	NULL
.	NULL

Stimulations	NULL
with	NULL
2	NULL
aM	NULL
ionomycin	NULL
plus	NULL
or	NULL
minus	NULL
20	NULL
ng/ml	NULL
PMA	NULL
were	NULL
started	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
were	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
7	NULL
h	NULL
before	NULL
harvesting	NULL
cells	NULL
for	NULL
luciferase	NULL
assays	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Reconstitution	NULL
of	NULL
NF-AT-Jurkat	NULL
cells	NULL
expressing	NULL
the	NULL
SV40	NULL
T	NULL
antigen	NULL
(	NULL
approximately	NULL
1.2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
as	NULL
above	NULL
using	NULL
either	NULL
10	NULL
ug	NULL
of	NULL
HisJunD	NULL
,	NULL
HisFos	NULL
,	NULL
or	NULL
SVFos	NULL
expression	NULL
vectors	NULL
or	NULL
20	NULL
ug	NULL
of	NULL
JunD	NULL
or	NULL
JunB	NULL
expression	NULL
vectors	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
36	NULL
h	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
suspending	NULL
cells	NULL
in	NULL
300	NULL
Ll	NULL
of	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
0.4	NULL
m	NULL
KCI	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.2	NULL
mm	NULL
PMSF	NULL
on	NULL
ice	NULL
.	NULL

This	NULL
cell	NULL
suspension	NULL
was	NULL
frozen	NULL
and	NULL
thawed	NULL
on	NULL
ice	NULL
two	NULL
times	NULL
and	NULL
then	NULL
spun	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
12	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
diluted	NULL
with	NULL
an	NULL
HNF	NULL
-	NULL
M	NULL
_	NULL
HNF	NULL
10	NULL
11	NULL
12	NULL
Components	NULL
of	NULL
NF-AT	NULL
A	NULL
The	NULL
Effect	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
Fra-1	NULL
Expression	NULL
on	NULL
NF-AT	NULL
Dependent	NULL
Transcription	NULL
J	NULL
Control	NULL
|	NULL
1	NULL
|	NULL
PI	NULL
[	NULL
N	NULL
MusFos	NULL
|	NULL
|	NULL
L	NULL
PI	NULL
[	NULL
N	NULL
cJun	NULL
I	NULL
L	NULL
PI	NULL
[	NULL
N	NULL
JunD	NULL
I	NULL
C	NULL
PI	NULL
[	NULL
N	NULL
JunB	NULL
|	NULL
|	NULL
C	NULL
PI	NULL
[	NULL
N	NULL
RatFos|	NULL
|	NULL
-	NULL
PI	NULL
(	NULL
N	NULL
Fra-1	NULL
|	NULL
|	NULL
-	NULL
PI	NULL
B	NULL
--	NULL
Ao	NULL
Teo	NULL
k	NULL
Ce	NULL
Expression	NULL
Condition	NULL
%	NULL
Activation	NULL
B	NULL
-	NULL
The	NULL
Effect	NULL
of	NULL
Fos	NULL
Expression	NULL
on	NULL
NFkB	NULL
and	NULL
IL2	NULL
Enhancer	NULL
Dependent	NULL
Transcription	NULL
L2	NULL
Control	NULL
NFkB	NULL
5	NULL
f	NULL
$	NULL
R	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
120	NULL
Reporter	NULL
Expression	NULL
Condition	NULL
%	NULL
Activation	NULL
Vector	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Expression	NULL
of	NULL
Fos	NULL
,	NULL
Fra	NULL
,	NULL
and	NULL
Jun	NULL
proteins	NULL
eliminate	NULL
the	NULL
PMA	NULL
requirement	NULL
for	NULL
NF-AT-dependent	NULL
transcription	NULL
.	NULL

Jurkat	NULL
cells	NULL
expressing	NULL
SV40	NULL
T	NULL
antigen	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
luciferase-based	NULL
reporter	NULL
constructs	NULL
for	NULL
(	NULL
A	NULL
)	NULL
NF-AT	NULL
and	NULL
(	NULL
B	NULL
)	NULL
NF	NULL
«	NULL
B	NULL
and	NULL
the	NULL
IL-2	NULL
enhancer	NULL
and	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
murine	NULL
cFos	NULL
,	NULL
cJun	NULL
,	NULL
JunD	NULL
,	NULL
JunB	NULL
,	NULL
rat	NULL
cFos	NULL
,	NULL
rat	NULL
Fra-1	NULL
,	NULL
or	NULL
pBJ5	NULL
control	NULL
plasmid	NULL
as	NULL
indicated	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
combined	NULL
PMA	NULL
and	NULL
ionomycin	NULL
stimulation	NULL
,	NULL
set	NULL
to	NULL
100	NULL
%	NULL
.	NULL

N	NULL
,	NULL
nonstimulated	NULL
;	NULL
I	NULL
,	NULL
ionomycin	NULL
alone	NULL
;	NULL
PZ	NULL
,	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Data	NULL
were	NULL
obtained	NULL
from	NULL
two	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
and	NULL
indicate	NULL
the	NULL
mean	NULL
plus	NULL
and	NULL
minus	NULL
the	NULL
range	NULL
of	NULL
values	NULL
obtained	NULL
.	NULL

equal	NULL
volume	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.2	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
passed	NULL
two	NULL
times	NULL
over	NULL
a	NULL
150-Ll	NULL
bed	NULL
volume	NULL
Ni°*-agarose	NULL
(	NULL
Quiagen	NULL
)	NULL
affinity	NULL
column	NULL
pre-equilibrated	NULL
with	NULL
buffer	NULL
B	NULL
containing	NULL
80	NULL
mm	NULL
KCl	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
buffer	NULL
B	NULL
containing	NULL
80	NULL
mM	NULL
KCl	NULL
and	NULL
20	NULL
mM	NULL
imidazole	NULL
(	NULL
3	NULL
X	NULL
200	NULL
ul	NULL
)	NULL
2919	NULL
and	NULL
then	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
three	NULL
150-4l	NULL
aliquots	NULL
of	NULL
buffer	NULL
B	NULL
containing	NULL
80	NULL
mM	NULL
KCl	NULL
and	NULL
100	NULL
mM	NULL
imidazole	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
column	NULL
load	NULL
and	NULL
flow-through	NULL
(	NULL
0.7	NULL
%	NULL
of	NULL
total	NULL
,	NULL
5	NULL
ul	NULL
)	NULL
and	NULL
elutions	NULL
(	NULL
3.3	NULL
%	NULL
of	NULL
total	NULL
,	NULL
5	NULL
ul	NULL
)	NULL
were	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
the	NULL
-specific	NULL
antisera	NULL
described	NULL
above	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
primary	NULL
antisera	NULL
was	NULL
detected	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-conjugated	NULL
rabbit	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Zymed	NULL
)	NULL
and	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Ni	NULL
#	NULL
*	NULL
column	NULL
fractions	NULL
(	NULL
elution	NULL
2	NULL
,	NULL
5	NULL
Ll	NULL
total	NULL
)	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
mixed	NULL
with	NULL
cytoplasmic	NULL
extract	NULL
(	NULL
5	NULL
ug	NULL
,	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
)	NULL
,	NULL
plus	NULL
or	NULL
minus	NULL
competitor	NULL
oligonucleotide	NULL
(	NULL
25	NULL
ng	NULL
)	NULL
were	NULL
allowed	NULL
to	NULL
associate	NULL
for	NULL
15	NULL
min	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
40	NULL
mm	NULL
NaCl	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
before	NULL
addition	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

Reactions	NULL
were	NULL
further	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
under	NULL
gel	NULL
mobility	NULL
shifts	NULL
.	NULL

Denaturation	NULL
and	NULL
Renaturation	NULL
of	NULL
NF-AT	NULL
-Crude	NULL
Jurkat	NULL
cytosol	NULL
was	NULL
enriched	NULL
approximately	NULL
50-fold	NULL
in	NULL
NF-ATc	NULL
activity	NULL
by	NULL
ammo-nium	NULL
sulfate	NULL
fractionation	NULL
and	NULL
ion	NULL
exchange	NULL
chromatography	NULL
.	NULL
``	NULL

This	NULL
material	NULL
(	NULL
250	NULL
ug	NULL
)	NULL
was	NULL
further	NULL
fractionated	NULL
by	NULL
reducing	NULL
SDS-PAGE	NULL
.	NULL

Gel	NULL
slices	NULL
were	NULL
crushed	NULL
and	NULL
proteins	NULL
eluted	NULL
for	NULL
15	NULL
h	NULL
at	NULL
25	NULL
°C	NULL
in	NULL
1.5	NULL
ml	NULL
of	NULL
elution	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCL	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
5	NULL
mm	NULL
DTT	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
40	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
)	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
gel	NULL
,	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
9	NULL
volumes	NULL
of	NULL
ice-cold	NULL
acetone	NULL
and	NULL
recovered	NULL
by	NULL
centrifugation	NULL
.	NULL

Pellets	NULL
were	NULL
dissolved	NULL
in	NULL
50	NULL
Ll	NULL
of	NULL
denaturing	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.03	NULL
%	NULL
lauryldimethylamine	NULL
oxide	NULL
,	NULL
and	NULL
6	NULL
M	NULL
guanidine	NULL
HCl	NULL
)	NULL
and	NULL
incubated	NULL
30	NULL
min	NULL
at	NULL
25°C	NULL
.	NULL

Samples	NULL
were	NULL
dialyzed	NULL
against	NULL
buffer	NULL
B	NULL
above	NULL
containing	NULL
50	NULL
mM	NULL
KCl	NULL
and	NULL
0.1	NULL
mM	NULL
EDTA	NULL
in	NULL
a	NULL
system	NULL
100	NULL
microdialyzer	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
these	NULL
samples	NULL
(	NULL
1	NULL
wl	NULL
)	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
enriched	NULL
NF-AT	NULL
'	NULL
c	NULL
starting	NULL
material	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

NF-ATc	NULL
was	NULL
assayed	NULL
in	NULL
10	NULL
ul	NULL
of	NULL
these	NULL
fractions	NULL
by	NULL
mixing	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
HeLa	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
20	NULL
ng/ml	NULL
PMA	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
above	NULL
under	NULL
``	NULL
Gel	NULL
Mobility	NULL
Shifts	NULL
.	NULL
``	NULL

RESULTS	NULL
As	NULL
shown	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
,	NULL
an	NULL
antisera	NULL
against	NULL
the	NULL
conserved	NULL
M	NULL
peptide	NULL
region	NULL
of	NULL
Fos	NULL
(	NULL
30	NULL
)	NULL
inhibited	NULL
NF-AT	NULL
binding	NULL
activity	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
there	NULL
is	NULL
no	NULL
inhibition	NULL
by	NULL
an	NULL
antisera	NULL
which	NULL
recognizes	NULL
hepatocyte	NULL
nuclear	NULL
factor-1a	NULL
(	NULL
HNF-1a	NULL
)	NULL
,	NULL
a	NULL
liver-enriched	NULL
transcription	NULL
factor	NULL
not	NULL
found	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
similar	NULL
results	NULL
with	NULL
the	NULL
anti-M	NULL
peptide	NULL
antisera	NULL
were	NULL
found	NULL
using	NULL
an	NULL
oligonucleotide	NULL
to	NULL
detect	NULL
AP1	NULL
binding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
inhibition	NULL
is	NULL
seen	NULL
of	NULL
Oct-1	NULL
DNA	NULL
binding	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
or	NULL
of	NULL
HNF-la	NULL
DNA	NULL
binding	NULL
(	NULL
lanes	NULL
10-12	NULL
)	NULL
.	NULL

The	NULL
HNF-1a	NULL
@	NULL
antisera	NULL
induces	NULL
a	NULL
supershift	NULL
of	NULL
of	NULL
slower	NULL
mobility	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
as	NULL
observed	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
an	NULL
entire	NULL
AP1	NULL
binding	NULL
activity	NULL
forms	NULL
a	NULL
component	NULL
of	NULL
NF-AT	NULL
,	NULL
we	NULL
performed	NULL
competitions	NULL
with	NULL
the	NULL
cognate	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
two	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
AP1	NULL
binding	NULL
activity	NULL
was	NULL
effectively	NULL
competed	NULL
by	NULL
excess	NULL
API	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
NF-AT	NULL
or	NULL
the	NULL
«	NULL
E2	NULL
site	NULL
of	NULL
the	NULL
immunoglobulin	NULL
«	NULL
enhancer	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
the	NULL
NF-AT	NULL
binding	NULL
site	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
cryptic	NULL
API	NULL
binding	NULL
site	NULL
.	NULL

Surprisingly	NULL
,	NULL
while	NULL
the	NULL
«	NULL
E2	NULL
site	NULL
does	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
NF-AT	NULL
binding	NULL
activity	NULL
,	NULL
the	NULL
API	NULL
site	NULL
competes	NULL
effectively	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NF-AT	NULL
contains	NULL
an	NULL
API	NULL
binding	NULL
activity	NULL
and	NULL
that	NULL
Fos	NULL
or	NULL
a	NULL
Fra	NULL
can	NULL
participate	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
of	NULL
NF-AT	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
AP1	NULL
binding	NULL
proteins	NULL
could	NULL
replace	NULL
the	NULL
requirement	NULL
for	NULL
PMA	NULL
stimulation	NULL
in	NULL
NF-AT-directed	NULL
transcription	NULL
,	NULL
we	NULL
cotransfected	NULL
either	NULL
murine	NULL
or	NULL
rat	NULL
c-fos	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
direction	NULL
of	NULL
NF-AT	NULL
.	NULL

Complete	NULL
independence	NULL
from	NULL
PMA	NULL
stimulation	NULL
is	NULL
observed	NULL
,	NULL
whereas	NULL
the	NULL
requirement	NULL
for	NULL
a	NULL
calcium	NULL
signal	NULL
remains	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Murine	NULL
Fos	NULL
appears	NULL
more	NULL
effective	NULL
than	NULL
rat	NULL
Fos	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Cotransfection	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
rat	NULL
Fra-1	NULL
,	NULL
which	NULL
was	NULL
isolated	NULL
by	NULL
virtue	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
it	NULL
is	NULL
immunologically	NULL
cross-reactive	NULL
with	NULL
Fos	NULL
(	NULL
32	NULL
)	NULL
,	NULL
also	NULL
replaces	NULL
the	NULL
PMA	NULL
signal	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
rat	NULL
Fos	NULL
.	NULL

There	NULL
was	NULL
no	NULL
effect	NULL
of	NULL
2920	NULL
Elutions	NULL
Cytosol	NULL
Column	NULL
Elution	NULL
Components	NULL
of	NULL
NF-AT	NULL
J	NULL
«	NULL
-=	NULL
J	NULL
Bf	NULL
HisD	NULL
HisD	NULL
D	NULL
_	NULL
D	NULL
w	NULL
}	NULL
His	NULL
ey	NULL
yA	NULL
JunD	NULL
~*~	NULL
came	NULL
|	NULL
AP1	NULL
-	NULL
>	NULL
FT	NULL
1	NULL
2	NULL
3	NULL
JunD	NULL
-	NULL
#	NULL
emm	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Cytosol	NULL
J	NULL
wn	NULL
J	NULL
w	NULL
J	NULL
C	NULL
C	NULL
J	NULL
J	NULL
P	NULL
3°	NULL
&	NULL
Column	NULL
Elution	NULL
Bf	NULL
HisD	NULL
HisD	NULL
D	NULL
D	NULL
Bf	NULL
HisD	NULL
HisD	NULL
HisD	NULL
¢°	NULL
«	NULL
t	NULL
‘	NULL
9	NULL
Nickel	NULL
Column	NULL
S	NULL
sf	NULL
“	NULL
?	NULL

&	NULL
Competitor	NULL
_	NULL
==	NULL
_	NULL
==	NULL
wee	NULL
we	NULL
s	NULL
e=	NULL
<	NULL
=	NULL
NF-AT	NULL
<	NULL
E2	NULL
Elution	NULL
$	NULL
¢	NULL
xy	NULL
1020	NULL
3	NULL
4	NULL
NF-AT	NULL
-	NULL
#	NULL
»	NULL
~	NULL
bet	NULL
<	NULL
-	NULL
Jun/Jun	NULL
Jun/Fos	NULL
wb	NULL
bth	NULL
#	NULL
,	NULL
,	NULL
<	NULL
>	NULL
=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Free	NULL
API	NULL
*+	NULL
Probe	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Reconstitution	NULL
of	NULL
NF-AT	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blot	NULL
of	NULL
Ni**-agarose	NULL
affinity	NULL
column	NULL
fractions	NULL
.	NULL

Jurkat	NULL
cells	NULL
expressing	NULL
SV40	NULL
T	NULL
antigen	NULL
were	NULL
transfected	NULL
using	NULL
either	NULL
HisJunD	NULL
expression	NULL
vector	NULL
plus	NULL
SVFos	NULL
vector	NULL
or	NULL
JunD	NULL
expression	NULL
vector	NULL
plus	NULL
SVFos	NULL
vector	NULL
and	NULL
extracts	NULL
made	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Aliquots	NULL
of	NULL
the	NULL
Ni**	NULL
column	NULL
flow-through	NULL
(	NULL
FT	NULL
)	NULL
and	NULL
each	NULL
elution	NULL
were	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
with	NULL
JunD-specific	NULL
antisera	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
elution	NULL
profile	NULL
for	NULL
His-tagged	NULL
JunD	NULL
,	NULL
and	NULL
the	NULL
bottom	NULL
panel	NULL
shows	NULL
profile	NULL
for	NULL
nontagged	NULL
JunD	NULL
.	NULL

B	NULL
,	NULL
reconstitution	NULL
of	NULL
NF-AT	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
Jurkat	NULL
(	NULL
J	NULL
)	NULL
and	NULL
Cos	NULL
(	NULL
C	NULL
)	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
indicated	NULL
.	NULL

Elution	NULL
2	NULL
from	NULL
A	NULL
was	NULL
used	NULL
as	NULL
indicated	NULL
.	NULL

HisD	NULL
,	NULL
elution	NULL
from	NULL
His-tagged	NULL
JunD	NULL
transfection	NULL
;	NULL
D	NULL
,	NULL
elution	NULL
from	NULL
nontagged	NULL
JunD	NULL
transfection	NULL
:	NULL
Bf	NULL
,	NULL
column	NULL
elution	NULL
buffer	NULL
.	NULL

Oligonucleotide	NULL
competitors	NULL
were	NULL
used	NULL
as	NULL
shown	NULL
.	NULL

The	NULL
labeled	NULL
NF-AT	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
.	NULL

C	NULL
,	NULL
API	NULL
binding	NULL
activity	NULL
in	NULL
affinity	NULL
column	NULL
elutions	NULL
.	NULL

These	NULL
five	NULL
lanes	NULL
contain	NULL
identical	NULL
components	NULL
to	NULL
lanes	NULL
1-5	NULL
in	NULL
B	NULL
except	NULL
that	NULL
a	NULL
labeled	NULL
AP1	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
prominent	NULL
lower	NULL
band	NULL
in	NULL
B	NULL
and	NULL
C	NULL
above	NULL
is	NULL
nonspecific	NULL
as	NULL
it	NULL
competes	NULL
with	NULL
both	NULL
oligonucleotides	NULL
.	NULL

The	NULL
free	NULL
probe	NULL
is	NULL
not	NULL
shown	NULL
.	NULL

D	NULL
,	NULL
nickel	NULL
column	NULL
elutions	NULL
contain	NULL
Jun/Jun	NULL
homodimers	NULL
and	NULL
Jun/Fos	NULL
heterodimers	NULL
.	NULL

Column	NULL
eluates	NULL
(	NULL
5	NULL
ul	NULL
total	NULL
,	NULL
elution	NULL
2	NULL
)	NULL
from	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
were	NULL
analyzed	NULL
for	NULL
AP1	NULL
binding	NULL
activity	NULL
as	NULL
in	NULL
C.	NULL
Lane	NULL
1	NULL
,	NULL
JunD	NULL
alone	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
Fos	NULL
alone	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
mix	NULL
of	NULL
JunD	NULL
and	NULL
Fos	NULL
:	NULL
and	NULL
lane	NULL
4	NULL
,	NULL
JunD	NULL
and	NULL
Fos	NULL
cotransfection	NULL
.	NULL

Arrows	NULL
indicate	NULL
Jun/Jun	NULL
homodimers	NULL
and	NULL
Jun/Fos	NULL
heterodimers	NULL
.	NULL

c-fos	NULL
cotransfection	NULL
on	NULL
NFxB-	NULL
or	NULL
IL-2-directed	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Fos	NULL
can	NULL
not	NULL
substitute	NULL
for	NULL
all	NULL
PMA	NULL
generated	NULL
signals	NULL
necessary	NULL
for	NULL
IL-2	NULL
expression	NULL
.	NULL

Since	NULL
Fos	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
an	NULL
API	NULL
site	NULL
as	NULL
a	NULL
monomer	NULL
or	NULL
homodimer	NULL
(	NULL
14-17	NULL
)	NULL
,	NULL
it	NULL
seemed	NULL
likely	NULL
that	NULL
the	NULL
competition	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
could	NULL
best	NULL
be	NULL
explained	NULL
if	NULL
Fos	NULL
or	NULL
a	NULL
Fra	NULL
were	NULL
complexed	NULL
with	NULL
a	NULL
Jun	NULL
protein	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
an	NULL
API	NULL
site	NULL
.	NULL

Cotransfection	NULL
of	NULL
expression	NULL
vectors	NULL
for	NULL
either	NULL
c-jun	NULL
or	NULL
junD	NULL
resulted	NULL
in	NULL
partial	NULL
independence	NULL
from	NULL
the	NULL
PMA	NULL
signal	NULL
for	NULL
induction	NULL
of	NULL
NF-AT	NULL
transcriptional	NULL
activity	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
jun	NULL
B	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

To	NULL
show	NULL
directly	NULL
that	NULL
Jun	NULL
proteins	NULL
are	NULL
capable	NULL
of	NULL
participating	NULL
in	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
we	NULL
overexpressed	NULL
JunD	NULL
tagged	NULL
with	NULL
histidine	NULL
and	NULL
nontagged	NULL
Fos	NULL
in	NULL
Jurkat	NULL
cells	NULL
which	NULL
constitutively	NULL
express	NULL
SV40	NULL
T	NULL
antigen	NULL
.	NULL

Extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
passed	NULL
over	NULL
Ni**-nitrilotriacetic	NULL
acid-agarose	NULL
affinity	NULL
columns	NULL
and	NULL
eluted	NULL
with	NULL
imidazole	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
using	NULL
a	NULL
JunD-specific	NULL
antisera	NULL
shows	NULL
that	NULL
the	NULL
His-tagged	NULL
JunD	NULL
is	NULL
found	NULL
predominantly	NULL
in	NULL
the	NULL
second	NULL
fraction	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
,	NULL
whereas	NULL
the	NULL
column	NULL
flow-through	NULL
is	NULL
effectively	NULL
depleted	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
wild-type	NULL
JunD	NULL
remains	NULL
in	NULL
the	NULL
flow-through	NULL
and	NULL
is	NULL
not	NULL
eluted	NULL
off	NULL
the	NULL
Ni**	NULL
column	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
nontagged	NULL
proteins	NULL
in	NULL
the	NULL
extract	NULL
which	NULL
elute	NULL
with	NULL
the	NULL
His-tagged	NULL
JunD	NULL
,	NULL
the	NULL
second	NULL
elution	NULL
fraction	NULL
from	NULL
each	NULL
column	NULL
was	NULL
used	NULL
in	NULL
reconstitution	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Although	NULL
neither	NULL
Jurkat	NULL
cytosol	NULL
nor	NULL
the	NULL
HisJunD	NULL
elution	NULL
alone	NULL
contain	NULL
NF-AT	NULL
binding	NULL
activity	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
mixing	NULL
these	NULL
two	NULL
fractions	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
resulted	NULL
in	NULL
regeneration	NULL
of	NULL
NF-AT	NULL
binding	NULL
activity	NULL
which	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
excess	NULL
NF-AT	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
JunD	NULL
does	NULL
not	NULL
appear	NULL
in	NULL
the	NULL
column	NULL
elution	NULL
and	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
this	NULL
elution	NULL
is	NULL
incapable	NULL
of	NULL
reconstituting	NULL
an	NULL
NF-AT	NULL
gel	NULL
shift	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
ability	NULL
to	NULL
regenerate	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
JunD	NULL
protein	NULL
.	NULL

Although	NULL
not	NULL
shown	NULL
here	NULL
,	NULL
we	NULL
assume	NULL
that	NULL
the	NULL
Components	NULL
of	NULL
NF-AT	NULL
2921	NULL
A	NULL
Transfected	NULL
Proteins	NULL
HisJunD/Fos	NULL
HisJunD	NULL
HisFos	NULL
HisFos/JunD	NULL
=	NULL
Probe	NULL
AP1	NULL
NF-AT	NULL
AP1	NULL
NF-AT	NULL
AP1	NULL
NF-AT	NULL
API	NULL
NF-AT	NULL
Cytosol	NULL
Competitor	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Participation	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
in	NULL
NF-AT	NULL
and	NULL
API	NULL
DNA	NULL
binding	NULL
activities	NULL
.	NULL

A	NULL
,	NULL
elution	NULL
2	NULL
from	NULL
nickel	NULL
columns	NULL
tested	NULL
for	NULL
API	NULL
binding	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Jurkat	NULL
cytosol	NULL
(	NULL
lanes	NULL
1-3	NULL
,	NULL
7-9	NULL
,	NULL
13-15	NULL
,	NULL
and	NULL
19-21	NULL
)	NULL
or	NULL
for	NULL
NF-AT	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Jurkat	NULL
cytosol	NULL
(	NULL
lanes	NULL
4-6	NULL
,	NULL
10-12	NULL
,	NULL
16-18	NULL
,	NULL
and	NULL
22-24	NULL
)	NULL
.	NULL

Lane	NULL
25	NULL
contains	NULL
Jurkat	NULL
cytosol	NULL
alone	NULL
with	NULL
the	NULL
NF-AT	NULL
probe	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
constructs	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Com	NULL
10	NULL
:	NULL
B	NULL
B	NULL
Transfected	NULL
Proteins	NULL
Column	NULL
Fraction	NULL
LOFT	NULL
petitor	NULL
oligonucleotides	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
-	NULL
,	NULL
44	NULL
none	NULL
;	NULL
A	NULL
,	NULL
AP1	NULL
;	NULL
K	NULL
,	NULL
«	NULL
E2	NULL
;	NULL
and	NULL
N	NULL
,	NULL
NF-AT	NULL
.	NULL

66.2-	NULL
B	NULL
,	NULL
Western	NULL
blot	NULL
of	NULL
load	NULL
(	NULL
L	NULL
)	NULL
,	NULL
flow	NULL
through	NULL
(	NULL
FT	NULL
)	NULL
,	NULL
and	NULL
elution	NULL
2	NULL
(	NULL
E2	NULL
)	NULL
of	NULL
so-nickel	NULL
columns	NULL
using	NULL
JunD-specific	NULL
anti-	NULL
{	NULL
0	NULL
e	NULL
sera	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
overexpressed	NULL
JunD	NULL
protein	NULL
.	NULL

C	NULL
,	NULL
enhancement	NULL
of	NULL
reconstituted	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
by	NULL
coexpression	NULL
of	NULL
JunB	NULL
with	NULL
Fos	NULL
.	NULL

Elution	NULL
2	NULL
from	NULL
nickel	NULL
columns	NULL
was	NULL
tested	NULL
alone	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
or	NULL
with	NULL
added	NULL
Jurkat	NULL
cytosol	NULL
(	NULL
lanes	NULL
3-5	NULL
and	NULL
7-9	NULL
)	NULL
for	NULL
NF-AT	NULL
binding	NULL
.	NULL

Lane	NULL
1	NULL
is	NULL
Jurkat	NULL
cytosol	NULL
alone	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
are	NULL
as	NULL
in	NULL
A	NULL
.	NULL

31.0	NULL
1	NULL
:	NULL
Probe	NULL
Transfected	NULL
Proteins	NULL
Cytosol	NULL
Competitor	NULL
overexpressed	NULL
Fos	NULL
copurifies	NULL
with	NULL
the	NULL
HisJunD	NULL
in	NULL
these	NULL
experiments	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
strong	NULL
interaction	NULL
through	NULL
the	NULL
leucine	NULL
zipper	NULL
motif	NULL
(	NULL
17	NULL
,	NULL
33-35	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
JunD/Fos	NULL
heterodimers	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
C	NULL
and	NULL
D	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
Cos	NULL
cell	NULL
cytosol	NULL
alone	NULL
or	NULL
when	NULL
combined	NULL
with	NULL
the	NULL
HisJunD	NULL
elution	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
fails	NULL
to	NULL
regenerate	NULL
NF-AT	NULL
binding	NULL
activity	NULL
.	NULL

This	NULL
confirms	NULL
the	NULL
T	NULL
cell-specific	NULL
nature	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
(	NULL
7	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
same	NULL
elution	NULL
fractions	NULL
alone	NULL
or	NULL
when	NULL
mixed	NULL
with	NULL
Jurkat	NULL
cytosol	NULL
for	NULL
AP1	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
column	NULL
elution	NULL
from	NULL
the	NULL
His-tagged	NULL
JunD	NULL
mo-	NULL
=	NULL
+	NULL
+	NULL
+	NULL
=-	NULL
A	NULL
Ko=	NULL
N	NULL
K	NULL
®	NULL
4	NULL
HisJu	NULL
Fos	NULL
-o-	NULL
-	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
=_	NULL
A	NULL
K	NULL
=	NULL
N	NULL
K	NULL
=	NULL
-o-	NULL
-	NULL
4+	NULL
+	NULL
+	NULL
=-	NULL
A	NULL
K	NULL
=	NULL
NOK	NULL
-o-	NULL
=	NULL
+	NULL
+	NULL
+	NULL
=_	NULL
A	NULL
K	NULL
=	NULL
N	NULL
K	NULL
alles	NULL
u	NULL
w	NULL
``	NULL
``	NULL
be	NULL
5	NULL
6	NULL
7	NULL
8s	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
HisFos/	NULL
JunD	NULL
E2	NULL
L	NULL
FT	NULL
E2	NULL
L	NULL
FT	NULL
E2	NULL
L	NULL
FI	NULL
E2	NULL
``	NULL
D/	NULL
viigunD	NULL
-	NULL
HisFoS	NULL
«	NULL
«	NULL
»	NULL
cup	NULL
--	NULL
«	NULL
ith	NULL
«	NULL
-	NULL
ae	NULL
Jun	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
NF-AT	NULL
-__	NULL
_	NULL
HisFos	NULL
_	NULL
-	NULL
HisFos/JunB	NULL
+o	NULL
-=	NULL
+	NULL
4+	NULL
+o	NULL
-	NULL
+++	NULL
=	NULL
=	NULL
N	NULL
K	NULL
-	NULL
=	NULL
N	NULL
K	NULL
N	NULL
u	NULL
<	NULL
-	NULL
NF-AT	NULL
k	NULL
(	NULL
%	NULL
§	NULL
|	NULL
8	NULL
88	NULL
bu	NULL
§	NULL
transfection	NULL
contains	NULL
AP1	NULL
binding	NULL
activity	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytosol	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
corresponding	NULL
elution	NULL
for	NULL
the	NULL
nontagged	NULL
JunD	NULL
does	NULL
not	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Two	NULL
specific	NULL
AP1	NULL
DNA	NULL
binding	NULL
activities	NULL
appear	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
an	NULL
upper	NULL
sharp	NULL
band	NULL
and	NULL
a	NULL
lower	NULL
more	NULL
diffuse	NULL
band	NULL
.	NULL

Expression	NULL
and	NULL
purification	NULL
of	NULL
His-tagged	NULL
JunD	NULL
alone	NULL
gives	NULL
rise	NULL
to	NULL
the	NULL
upper	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
His-tagged	NULL
Fos	NULL
alone	NULL
gives	NULL
rise	NULL
to	NULL
no	NULL
detectable	NULL
AP1	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Mixing	NULL
purified	NULL
HisJunD	NULL
with	NULL
HisFos	NULL
reconstitutes	NULL
the	NULL
lower	NULL
band	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
present	NULL
when	NULL
Jun	NULL
and	NULL
Fos	NULL
2922	NULL
Components	NULL
of	NULL
NF-AT	NULL
A	NULL
B	NULL
SDS-PAGE	NULL
Reconstitution	NULL
of	NULL
NF-AT	NULL
Cytosol	NULL
Cytosol	NULL
Fraction	NULL
#	NULL
|	NULL
-	NULL
102	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
L	NULL
m—	NULL
116-974	NULL
-66.2-	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Renaturation	NULL
of	NULL
NF-ATc	NULL
.	NULL

A	NULL
,	NULL
SDS-PAGE	NULL
of	NULL
load	NULL
(	NULL
L	NULL
)	NULL
and	NULL
elutions	NULL
(	NULL
1-9	NULL
)	NULL
of	NULL
gel	NULL
slices	NULL
.	NULL

Molecular	NULL
mass	NULL
ranges	NULL
for	NULL
the	NULL
fractions	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
fraction	NULL
1	NULL
,	NULL
<	NULL
48	NULL
kDa	NULL
;	NULL
fraction	NULL
2	NULL
,	NULL
48-59	NULL
kDa	NULL
;	NULL
fraction	NULL
3	NULL
,	NULL
59-78	NULL
kDa	NULL
;	NULL
fraction	NULL
4	NULL
,	NULL
78-94	NULL
kDa	NULL
;	NULL
fraction	NULL
5	NULL
,	NULL
94-116	NULL
kDa	NULL
;	NULL
fraction	NULL
6	NULL
,	NULL
116-143	NULL
kDa	NULL
;	NULL
fraction	NULL
7	NULL
,	NULL
143-185	NULL
kDa	NULL
;	NULL
fraction	NULL
8	NULL
,	NULL
185-225	NULL
kDa	NULL
;	NULL
9	NULL
,	NULL
>	NULL
225	NULL
kDa	NULL
.	NULL

Gel	NULL
is	NULL
silver-stained	NULL
.	NULL

The	NULL
broad	NULL
band	NULL
in	NULL
each	NULL
lane	NULL
above	NULL
the	NULL
66.2-kDa	NULL
marker	NULL
is	NULL
bovine	NULL
serum	NULL
albumin	NULL
carrier	NULL
.	NULL

B	NULL
,	NULL
reconstitution	NULL
of	NULL
NF-AT	NULL
using	NULL
cytosol	NULL
fractions	NULL
(	NULL
1-9	NULL
)	NULL
and	NULL
gel	NULL
load	NULL
(	NULL
L	NULL
)	NULL
mixed	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

Left-most	NULL
lane	NULL
(	NULL
-	NULL
)	NULL
contains	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
alone	NULL
.	NULL

Arrow	NULL
points	NULL
to	NULL
specific	NULL
NF-AT	NULL
complex	NULL
.	NULL

are	NULL
coexpressed	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

We	NULL
interpret	NULL
these	NULL
results	NULL
as	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
Jun/Jun	NULL
homodimers	NULL
(	NULL
upper	NULL
band	NULL
)	NULL
and	NULL
Jun/Fos	NULL
heterodimers	NULL
(	NULL
lower	NULL
band	NULL
)	NULL
.	NULL

Since	NULL
expression	NULL
of	NULL
JunD	NULL
alone	NULL
replaces	NULL
the	NULL
PMA	NULL
requirement	NULL
for	NULL
NF-AT-directed	NULL
transcription	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
JunD	NULL
alone	NULL
could	NULL
reconstitute	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
.	NULL

Addition	NULL
of	NULL
cytosol	NULL
to	NULL
JunD	NULL
homodimers	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
results	NULL
in	NULL
reconstituted	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
with	NULL
the	NULL
correct	NULL
specificity	NULL
(	NULL
lanes	NULL
10-12	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
functional	NULL
data	NULL
presented	NULL
above	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
reconstitution	NULL
using	NULL
coexpressed	NULL
JunD	NULL
and	NULL
Fos	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
1-6	NULL
.	NULL

Jurkat	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
Fos	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
stimulation	NULL
(	NULL
22	NULL
)	NULL
;	NULL
however	NULL
,	NULL
JunD	NULL
is	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
nonstimu-lated	NULL
Jurkat	NULL
cells	NULL
``	NULL
and	NULL
therefore	NULL
is	NULL
available	NULL
to	NULL
pair	NULL
with	NULL
exogenously	NULL
expressed	NULL
Fos	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
why	NULL
expression	NULL
of	NULL
Fos	NULL
or	NULL
Fra-1	NULL
alone	NULL
can	NULL
functionally	NULL
replace	NULL
the	NULL
PMA	NULL
signal	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
Fos	NULL
alone	NULL
could	NULL
reconstitute	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
,	NULL
cytosol	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nickel	NULL
column	NULL
elution	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
and	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
13-15	NULL
.	NULL

A	NULL
very	NULL
small	NULL
amount	NULL
of	NULL
NF-AT	NULL
can	NULL
be	NULL
detected	NULL
(	NULL
compare	NULL
lanes	NULL
16	NULL
and	NULL
25	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
functional	NULL
assay	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
is	NULL
far	NULL
more	NULL
sensitive	NULL
than	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Coexpression	NULL
of	NULL
JunD	NULL
with	NULL
HisFos	NULL
results	NULL
in	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
Jun/Fos	NULL
heterodimer	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
19-21	NULL
)	NULL
and	NULL
consequently	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
reconstituted	NULL
NF-AT	NULL
(	NULL
lanes	NULL
22-24	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
reconstituted	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
immunoreactive	NULL
JunD	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
JunD	NULL
is	NULL
easily	NULL
detected	NULL
in	NULL
fractions	NULL
able	NULL
to	NULL
reconstitute	NULL
appreciable	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
HisFos/JunD	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
12	NULL
,	NULL
E2	NULL
)	NULL
.	NULL

A	NULL
longer	NULL
exposure	NULL
of	NULL
this	NULL
blot	NULL
shows	NULL
some	NULL
JunD	NULL
copurifying	NULL
with	NULL
the	NULL
HisFos	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
Western	NULL
blot	NULL
is	NULL
yet	NULL
less	NULL
sensitive	NULL
than	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Since	NULL
JunB	NULL
is	NULL
unable	NULL
to	NULL
transactivate	NULL
the	NULL
NF-ATLuc	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
it	NULL
could	NULL
participate	NULL
in	NULL
the	NULL
NF-AT	NULL
complex	NULL
.	NULL

Coexpression	NULL
of	NULL
JunB	NULL
with	NULL
HisFos	NULL
enhances	NULL
reconstituted	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
as	NULL
°	NULL
K.	NULL
Ullman	NULL
and	NULL
G.	NULL
Crabtree	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

did	NULL
JunD	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
JunB	NULL
can	NULL
participate	NULL
in	NULL
a	NULL
nonfunctional	NULL
NF-AT	NULL
complex	NULL
.	NULL

To	NULL
begin	NULL
characterization	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NF-AT	NULL
,	NULL
we	NULL
fractionated	NULL
Jurkat	NULL
cytosol	NULL
enriched	NULL
in	NULL
NF-ATc	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
renatured	NULL
proteins	NULL
eluted	NULL
form	NULL
gel	NULL
slices	NULL
.	NULL

These	NULL
fractions	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
.	NULL

Using	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
as	NULL
a	NULL
source	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
(	NULL
7	NULL
)	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
reconstitute	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
specifically	NULL
from	NULL
three	NULL
fractions	NULL
(	NULL
fractions	NULL
4-6	NULL
,	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
but	NULL
mostly	NULL
from	NULL
fraction	NULL
5	NULL
(	NULL
94-116	NULL
kDa	NULL
)	NULL
.	NULL

The	NULL
reconstituted	NULL
complexes	NULL
migrate	NULL
slower	NULL
in	NULL
the	NULL
gel	NULL
with	NULL
higher	NULL
molecular	NULL
mass	NULL
fractions	NULL
,	NULL
and	NULL
each	NULL
forms	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
NF-AT	NULL
reconstituted	NULL
from	NULL
the	NULL
starting	NULL
material	NULL
(	NULL
L	NULL
)	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
forms	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
.	NULL

DISCUSSION	NULL
Based	NULL
on	NULL
our	NULL
results	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
human	NULL
NF-AT	NULL
contains	NULL
both	NULL
a	NULL
PMA-inducible	NULL
and	NULL
relatively	NULL
ubiquitous	NULL
API	NULL
binding	NULL
activity	NULL
,	NULL
forming	NULL
the	NULL
nuclear	NULL
component	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
T	NULL
cell-restricted	NULL
cytosolic	NULL
component	NULL
.	NULL

Recent	NULL
work	NULL
(	NULL
23	NULL
)	NULL
has	NULL
implicated	NULL
AP1	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
inducible	NULL
murine	NULL
NF-AT	NULL
complex	NULL
.	NULL

Our	NULL
results	NULL
confirm	NULL
this	NULL
notion	NULL
for	NULL
the	NULL
human	NULL
NF-AT	NULL
complex	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
Fos	NULL
,	NULL
Fra	NULL
,	NULL
and	NULL
Jun	NULL
proteins	NULL
can	NULL
eliminate	NULL
the	NULL
need	NULL
for	NULL
PMA	NULL
induction	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
and	NULL
characterize	NULL
which	NULL
Jun	NULL
proteins	NULL
are	NULL
functional	NULL
and	NULL
which	NULL
are	NULL
able	NULL
to	NULL
reconstitute	NULL
NF-AT	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
.	NULL

The	NULL
nuclear	NULL
component	NULL
of	NULL
human	NULL
NF-AT	NULL
appears	NULL
to	NULL
contain	NULL
both	NULL
a	NULL
Jun	NULL
family	NULL
member	NULL
and	NULL
Fos	NULL
or	NULL
a	NULL
Fra	NULL
.	NULL

Functionally	NULL
,	NULL
both	NULL
eJun	NULL
and	NULL
JunD	NULL
operate	NULL
to	NULL
replace	NULL
the	NULL
PMA	NULL
requirement	NULL
as	NULL
does	NULL
Fos	NULL
and	NULL
Fra-1	NULL
.	NULL

Although	NULL
the	NULL
effect	NULL
of	NULL
cJun	NULL
or	NULL
JunD	NULL
is	NULL
not	NULL
nearly	NULL
as	NULL
pronounced	NULL
as	NULL
that	NULL
of	NULL
Fos	NULL
,	NULL
this	NULL
may	NULL
reflect	NULL
known	NULL
differences	NULL
between	NULL
the	NULL
transcriptional	NULL
activation	NULL
potential	NULL
of	NULL
cJun	NULL
homodimers	NULL
as	NULL
compared	NULL
with	NULL
cJun/Fos	NULL
heterodimers	NULL
at	NULL
a	NULL
12-O-tetradecanoylphorbol-13-acetate-responsive	NULL
element	NULL
(	NULL
15	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Although	NULL
JunB	NULL
is	NULL
able	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
NF-AT	NULL
complex	NULL
,	NULL
it	NULL
is	NULL
not	NULL
able	NULL
to	NULL
activate	NULL
an	NULL
NF-AT-dependent	NULL
reporter	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
provocative	NULL
given	NULL
previous	NULL
studies	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
showing	NULL
differences	NULL
in	NULL
the	NULL
transactivation	NULL
Components	NULL
of	NULL
NF-AT	NULL
potential	NULL
and	NULL
mutual	NULL
antagonism	NULL
between	NULL
cJun	NULL
and	NULL
JunB	NULL
on	NULL
certain	NULL
12-O-tetradecanoylphorbol-13-acetate-responsive	NULL
element	NULL
constructs	NULL
and	NULL
in	NULL
malignant	NULL
transformation	NULL
assays	NULL
.	NULL

There	NULL
is	NULL
some	NULL
evidence	NULL
(	NULL
23	NULL
)	NULL
that	NULL
NF-ATc	NULL
can	NULL
bind	NULL
a	NULL
specific	NULL
DNA	NULL
sequence	NULL
independently	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
.	NULL

Thus	NULL
,	NULL
given	NULL
the	NULL
similarities	NULL
between	NULL
NF-AT	NULL
and	NULL
API	NULL
transactivation	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
activities	NULL
of	NULL
various	NULL
Jun	NULL
and	NULL
Fos	NULL
family	NULL
members	NULL
,	NULL
NF-AT	NULL
may	NULL
serve	NULL
to	NULL
couple	NULL
API	NULL
to	NULL
a	NULL
new	NULL
DNA	NULL
binding	NULL
site	NULL
where	NULL
Jun	NULL
and	NULL
Fos	NULL
contribute	NULL
all	NULL
transcriptional	NULL
activation	NULL
functions	NULL
.	NULL

Antibody	NULL
inhibition	NULL
and	NULL
functional	NULL
studies	NULL
implicate	NULL
Fos	NULL
or	NULL
a	NULL
Fra	NULL
as	NULL
a	NULL
participant	NULL
in	NULL
the	NULL
NF-AT	NULL
complex	NULL
.	NULL

Although	NULL
the	NULL
native	NULL
NF-AT	NULL
complex	NULL
includes	NULL
Fos	NULL
or	NULL
a	NULL
Fra	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
both	NULL
functionally	NULL
and	NULL
by	NULL
reconstitution	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
that	NULL
Fos	NULL
is	NULL
not	NULL
necessary	NULL
and	NULL
that	NULL
cJun	NULL
and	NULL
JunD	NULL
are	NULL
sufficient	NULL
to	NULL
replace	NULL
the	NULL
nuclear	NULL
component	NULL
.	NULL

Expression	NULL
of	NULL
Fos	NULL
of	NULL
Fra-l1	NULL
functionally	NULL
activate	NULL
NF-AT-dependent	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
likely	NULL
because	NULL
of	NULL
consti-tuitive	NULL
low	NULL
level	NULL
expression	NULL
of	NULL
Jun	NULL
proteins	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
Fos	NULL
gene	NULL
family	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
members	NULL
already	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
grow	NULL
;	NULL
thus	NULL
it	NULL
remains	NULL
a	NULL
formal	NULL
possibility	NULL
that	NULL
the	NULL
native	NULL
NF-AT	NULL
complex	NULL
in	NULL
Jurkat	NULL
cells	NULL
contains	NULL
an	NULL
as	NULL
yet	NULL
unidentified	NULL
Fra	NULL
,	NULL
pairing	NULL
with	NULL
Jun	NULL
.	NULL

NF-AT	NULL
,	NULL
not	NULL
only	NULL
serves	NULL
to	NULL
couple	NULL
API	NULL
to	NULL
the	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
site	NULL
but	NULL
also	NULL
imparts	NULL
dependence	NULL
on	NULL
a	NULL
calcium	NULL
flux	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
sensitivity	NULL
to	NULL
CsA	NULL
and	NULL
FK506	NULL
.	NULL

Therefore	NULL
,	NULL
with	NULL
regard	NULL
to	NULL
calcium-mediated	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
immunosupressant	NULL
action	NULL
,	NULL
NF-ATc	NULL
is	NULL
a	NULL
key	NULL
component	NULL
.	NULL

We	NULL
have	NULL
partially	NULL
purified	NULL
this	NULL
protein	NULL
and	NULL
shown	NULL
it	NULL
to	NULL
have	NULL
a	NULL
molecular	NULL
mass	NULL
between	NULL
94	NULL
and	NULL
116	NULL
kDa	NULL
.	NULL

NF-ATc	NULL
is	NULL
present	NULL
in	NULL
more	NULL
than	NULL
one	NULL
molecular	NULL
mass	NULL
range	NULL
,	NULL
indicating	NULL
some	NULL
heterogeneity	NULL
in	NULL
this	NULL
factor	NULL
.	NULL

This	NULL
heterogeneity	NULL
is	NULL
unlikely	NULL
due	NULL
to	NULL
proteolysis	NULL
during	NULL
the	NULL
denaturation-renaturation	NULL
steps	NULL
as	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
reconstituted	NULL
complexes	NULL
all	NULL
fall	NULL
within	NULL
the	NULL
range	NULL
of	NULL
the	NULL
native	NULL
NF-AT	NULL
complex	NULL
isolated	NULL
from	NULL
the	NULL
nuclei	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Purification	NULL
and	NULL
cloning	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
NF-ATc	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
fully	NULL
answer	NULL
these	NULL
questions	NULL
.	NULL

Although	NULL
the	NULL
full	NULL
nature	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
of	NULL
NF-AT	NULL
is	NULL
not	NULL
known	NULL
,	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
API	NULL
acquires	NULL
the	NULL
specificity	NULL
of	NULL
NF-AT	NULL
,	NULL
thereby	NULL
explaining	NULL
how	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
like	NULL
AP1	NULL
can	NULL
contribute	NULL
to	NULL
the	NULL
biologically	NULL
specific	NULL
pattern	NULL
of	NULL
early	NULL
gene	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
D.	NULL
Mendel	NULL
and	NULL
L.	NULL
Hansen	NULL
for	NULL
rat	NULL
liver	NULL
nuclear	NULL
extract	NULL
and	NULL
antisera	NULL
to	NULL
HNF-1a	NULL
@	NULL
,	NULL
respectively	NULL
;	NULL
T.	NULL
Curran	NULL
and	NULL
L.	NULL
Sambucetti	NULL
for	NULL
antisera	NULL
to	NULL
Fos	NULL
and	NULL
the	NULL
rat	NULL
fra-1	NULL
and	NULL
c-fos	NULL
cDNAs	NULL
;	NULL
M.	NULL
Yaniv	NULL
for	NULL
expression	NULL
vectors	NULL
for	NULL
murine	NULL
cJun	NULL
,	NULL
JunD	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
cFos	NULL
;	NULL
N.	NULL
Nomura	NULL
for	NULL
the	NULL
human	NULL
JunD	NULL
clone	NULL
;	NULL
and	NULL
P.	NULL
Kao	NULL
for	NULL
the	NULL
NF-ATLuc	NULL
construct	NULL
.	NULL

©	NULL
po-	NULL
®	NULL
grom	NULL
@	NULL
br	NULL
0	NULL
-o	NULL
ome	NULL
mo	NULL
-o	NULL
o	NULL
im	NULL
co	NULL
No	NULL
b	NULL
0	NULL
N	NULL
No	NULL
Roo	NULL
kb	NULL
oH	NULL
e	NULL
os	NULL
mo	NULL
c	NULL
Nom	NULL
0	NULL
©	NULL
po	NULL
u	NULL
®	NULL
a	NULL
to	NULL
bo	NULL
®	NULL
or	NULL
bo	NULL
-1	NULL
bo	NULL
bo	NULL
w	NULL
go	NULL
to	NULL
-	NULL
go	NULL
mo	NULL
o	NULL
99	NULL
oo	NULL
05	NULL
bo	NULL
mo	NULL
5	NULL
-	NULL
w	NULL
®	NULL
On	NULL
om	NULL
co	NULL
to	NULL
go	NULL
~1	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
.	NULL

Verweij	NULL
,	NULL
20923	NULL
REFERENCES	NULL
.	NULL

Gillis	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Nature	NULL
268	NULL
,	NULL
154-156	NULL
.	NULL

Blackman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Tigges	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Minie	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
609-617	NULL
.	NULL

O'Garra	NULL
,	NULL
A.	NULL
,	NULL
Umland	NULL
,	NULL
S.	NULL
,	NULL
DeFrance	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Christiansen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Immu-	NULL
nol	NULL
.	NULL

Today	NULL
9	NULL
,	NULL
45-54	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belageje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
C.	NULL
L.	NULL
,	NULL
Guidos	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Bicl	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
15788-15795	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
352	NULL
,	NULL
803-807	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
1487-1491	NULL
.	NULL

Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Wamsley	NULL
,	NULL
P.	NULL
,	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
334	NULL
,	NULL
629-631	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Hirai	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
834	NULL
,	NULL
535-597	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8464-8467	NULL
.	NULL

Hirai	NULL
,	NULL
S.-I	NULL
.	NULL

,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Mechta	NULL
,	NULL
F.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1433-1439	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
907-915	NULL
.	NULL

Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
289	NULL
,	NULL
1150-1153	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
541-552	NULL
.	NULL

Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Sambucetti	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Distel	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Spiegelman	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
471-480	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
692-695	NULL
.	NULL

Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Ferreira	NULL
,	NULL
P.	NULL
C.	NULL
P.	NULL
,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
173-184	NULL
.	NULL

Zerial	NULL
,	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
805-813	NULL
.	NULL

Nishina	NULL
,	NULL
H.	NULL
,	NULL
Sato	NULL
,	NULL
H.	NULL
,	NULL
Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Sato	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Iba	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
3619-3623	NULL
.	NULL

Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Alpers	NULL
,	NULL
J	NULL
,	NULL
D.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Hoover	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

83	NULL
,	NULL
3982-3986	NULL
.	NULL

Mattila	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Fiering	NULL
,	NULL
S.	NULL
,	NULL
McCutcheon	NULL
,	NULL
M.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4425-4483	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
356	NULL
,	NULL
801-804	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Merlino	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
Willingham	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Pastan	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

79	NULL
,	NULL
6777-6781	NULL
.	NULL

Southern	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Berg	NULL
,	NULL
P.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Appl	NULL
.	NULL

Genet	NULL
.	NULL

1	NULL
,	NULL
327-341	NULL
.	NULL

Fiering	NULL
,	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Mattila	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1823-1834	NULL
.	NULL

Mendel	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Hansen	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Graves	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Conley	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1042-1056	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
357	NULL
,	NULL
695-697	NULL
.	NULL

Baumhueter	NULL
,	NULL
S.	NULL
,	NULL
Courtois	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
2485-2403	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
van	NULL
Beveren	NULL
,	NULL
N.	NULL
,	NULL
Ling	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
167-172	NULL
.	NULL

de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
Deluca	NULL
,	NULL
M.	NULL
,	NULL
Helinski	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
725-737	NULL
.	NULL

Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
2063-2069	NULL
.	NULL

Landschulz	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
1759-1764	NULL
.	NULL

Neuberg	NULL
,	NULL
M.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Hunter	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
338	NULL
,	NULL
589-590	NULL
.	NULL

Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Neuberg	NULL
,	NULL
M.	NULL
,	NULL
Hunter	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Muller	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
507-516	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Kamps	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
553-560	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
979-986	NULL
.	NULL

Schiitte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
987-997	NULL

